These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1679 related articles for article (PubMed ID: 34092429)

  • 21. Vaccination-Associated Myocarditis and Myocardial Injury.
    Altman NL; Berning AA; Mann SC; Quaife RA; Gill EA; Auerbach SR; Campbell TB; Bristow MR
    Circ Res; 2023 May; 132(10):1338-1357. PubMed ID: 37167355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
    Beckley M; Olson AK; Portman MA
    JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global reports of myocarditis following COVID-19 vaccination: A systematic review and meta-analysis.
    Ahmed SK; Mohamed MG; Essa RA; Ahmed Rashad EA; Ibrahim PK; Khdir AA; Wsu ZH
    Diabetes Metab Syndr; 2022 Jun; 16(6):102513. PubMed ID: 35660931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BNT162b2 immunization-related myocarditis in adolescents and consequent hospitalization: Report from a medical center.
    Yen CW; Lee J; Chang YT; Lee EP; Wu CT; Chang YJ
    Pediatr Neonatol; 2023 Nov; 64(6):659-666. PubMed ID: 37302919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine.
    Park S; You J
    J Korean Med Sci; 2022 Apr; 37(16):e131. PubMed ID: 35470603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute Myocarditis after COVID-19 vaccination: A case report.
    Schmitt P; Demoulin R; Poyet R; Capilla E; Rohel G; Pons F; Jégo C; Sidibe S; Druelle A; Brocq FX; Dutasta F; Cellarier GR
    Rev Med Interne; 2021 Nov; 42(11):797-800. PubMed ID: 34740463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age.
    Das BB; Kohli U; Ramachandran P; Nguyen HH; Greil G; Hussain T; Tandon A; Kane C; Avula S; Duru C; Hede S; Sharma K; Chowdhury D; Patel S; Mercer C; Chaudhuri NR; Patel B; Ang JY; Asmar B; Sanchez J; Khan D
    J Pediatr; 2021 Nov; 238():26-32.e1. PubMed ID: 34339728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases.
    Wong HL; Hu M; Zhou CK; Lloyd PC; Amend KL; Beachler DC; Secora A; McMahill-Walraven CN; Lu Y; Wu Y; Ogilvie RP; Reich C; Djibo DA; Wan Z; Seeger JD; Akhtar S; Jiao Y; Chillarige Y; Do R; Hornberger J; Obidi J; Forshee R; Shoaibi A; Anderson SA
    Lancet; 2022 Jun; 399(10342):2191-2199. PubMed ID: 35691322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute myocarditis following a third dose of COVID-19 mRNA vaccination in adults.
    Simone A; Herald J; Chen A; Nayak R; Shen YA; Lee MS
    Int J Cardiol; 2022 Oct; 365():41-43. PubMed ID: 35870635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocarditis following COVID-19 vaccination in adolescents and adults: a cumulative experience of 2021.
    Ilonze OJ; Guglin ME
    Heart Fail Rev; 2022 Nov; 27(6):2033-2043. PubMed ID: 35449353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac sequelae in athletes following COVID-19 vaccination: evidence and misinformation.
    Daems JJN; van Hattum JC; Verwijs SM; Bijsterveld NR; Groenink M; Wilde AAM; Pinto YM; Jorstad HT
    Br J Sports Med; 2023 Nov; 57(21):1400-1402. PubMed ID: 37562938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study.
    Husby A; Hansen JV; Fosbøl E; Thiesson EM; Madsen M; Thomsen RW; Sørensen HT; Andersen M; Wohlfahrt J; Gislason G; Torp-Pedersen C; Køber L; Hviid A
    BMJ; 2021 Dec; 375():e068665. PubMed ID: 34916207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mRNA vaccines for COVID-19 are safe and clinically effective in patients with cardiac amyloidosis.
    Barzen G; Rieber F; Stangl K; Hahn K; Spethmann S
    Vaccine; 2024 Feb; 42(4):723-726. PubMed ID: 38158299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Hypersensitivity Reaction.
    Ameratunga R; Woon ST; Sheppard MN; Garland J; Ondruschka B; Wong CX; Stewart RAH; Tatley M; Stables SR; Tse RD
    J Clin Immunol; 2022 Apr; 42(3):441-447. PubMed ID: 34978002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 mRNA vaccine-associated encephalopathy, myocarditis, and thrombocytopenia with excellent response to methylprednisolone: A case report.
    Asaduzzaman M; Purkayastha B; Alam MMJ; Chakraborty SR; Roy S; Ahmed N
    J Neuroimmunol; 2022 Jul; 368():577883. PubMed ID: 35561428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine.
    Azir M; Inman B; Webb J; Tannenbaum L
    J Emerg Med; 2021 Dec; 61(6):e129-e132. PubMed ID: 34756746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paediatric safety assessment of BNT162b2 vaccination in a multistate hospital-based electronic health record system in the USA: a retrospective analysis.
    Matson RP; Niesen MJM; Levy ER; Opp DN; Lenehan PJ; Donadio G; O'Horo JC; Venkatakrishnan AJ; Badley AD; Soundararajan V
    Lancet Digit Health; 2023 Apr; 5(4):e206-e216. PubMed ID: 36963910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute Perimyocarditis in an Adolescent Japanese Male after a Booster Dose of the BNT162b2 COVID-19 Vaccine.
    Morita Y; Matsubara D; Seki M; Tamura D; Tajima T
    Tohoku J Exp Med; 2022 Oct; 258(3):177-182. PubMed ID: 36002252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine: A Case Report.
    Al-Rasbi S; Al-Maqbali JS; Al-Farsi R; Al Shukaili MA; Al-Riyami MH; Al Falahi Z; Al Farhan H; Al Alawi AM
    Am J Case Rep; 2022 Feb; 23():e934399. PubMed ID: 35173141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 84.